Drug
Avelumab KG Q2w
Avelumab KG Q2w: highest development phase Phase 1, developed by Merck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Avelumab 3 mg/kg Q2W NCT03523390 | Phase 1 | Metastatic Solid Tumors |
Latest
No recent events.
Follow Avelumab KG Q2w on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.